Delivery Order SPE2DB22D1017-SPE2DB25FG8RW
- Not listed
- The Defense Logistics Agency awarded a $7,021.91 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML autoinjector on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-set-aside award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic medication used to treat inflammatory conditions including psoriasis, psoriatic arthritis, and ankylosing spondylitis, representing...
- The Defense Logistics Agency awarded a delivery order valued at $1,660.30 to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL autoinjector on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order...
- The Defense Logistics Agency awarded a delivery order valued at $8,894.37 to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML Autoinjector on August 25, 2025, with completion scheduled for August 26, 2025. This competitive award, utilizing firm fixed pricing with no set-aside designation, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the company's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $6,641.24 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector on August 7, 2025, with completion scheduled for August 8, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designations and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic immunosuppressant used to treat autoimmune conditions including psoriasis,...
- The Defense Logistics Agency awarded a delivery order valued at $6,665.40 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed price delivery order represents a non-competitive procurement under an existing contract vehicle. TALTZ (ixekizumab) is a biologic immunosuppressant used to treat autoimmune conditions including psoriasis and rheumatoid arthritis. The performance will take place at...
- The Defense Logistics Agency awarded a delivery order valued at $25,456.25 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector on September 16, 2025, with an ultimate completion date of September 17, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic medication commonly used to treat autoimmune...
- The Defense Logistics Agency awarded a delivery order valued at $12,936.14 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector on June 17, 2025, with completion scheduled for June 18, 2025. TALTZ is a biologic medication used to treat autoimmune conditions including psoriasis, psoriatic arthritis, and ankylosing spondylitis. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the company's corporate headquarters in...
- The Defense Logistics Agency awarded a $21,972.38 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of TALTZ 80 mg/mL autoinjectors. This firm fixed-price delivery order, which is expected to be completed by August 25, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a $15,104.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector on May 16, 2025, with an ultimate completion date of May 19, 2025. This contract is a non-set-aside award and represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with the DLA. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of TALTZ 80 mg/ml auto-injector two-packs with a ceiling value of $8,391.13. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG8RWDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,980.90 to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL autoinjector on July 31, 2025, with an ultimate completion date of August 1, 2025. This firm fixed price delivery order, issued without set-aside designation, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic medication primarily used to treat autoimmune and inflammatory conditions including psoriasis, psoriatic arthritis, and ankylosing spondylitis. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a broad range of pharmaceuticals and medical supplies to support military healthcare programs and other government healthcare systems. The company has demonstrated consistent capability to fulfill federal medical supply requirements through open competition, with delivery orders typically featuring firm fixed pricing and covering diverse therapeutic domains across multiple product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 7/31/25 |